Cargando…
Diagnostic tools should be used for the diagnosis of chemotherapy induced peripheral neuropathy in breast cancer patients receiving taxanes
BACKGROUND: Though the incidence, characteristics, and pathogenesis of chemotherapy induced peripheral neuropathy (CIPN) by taxane based chemotherapy were extensively studied, diagnostic guidelines extent only recently. AIM: To observationally investigate whether specific tests can be used to predic...
Autores principales: | van Haren, Frank, van den Heuvel, Sandra, Ligtenberg, Mandy, Vissers, Kris, Steegers, Monique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575489/ https://www.ncbi.nlm.nih.gov/pubmed/34687287 http://dx.doi.org/10.1002/cnr2.1577 |
Ejemplares similares
-
Intravenous Lidocaine: Old-School Drug, New Purpose—Reduction of Intractable Pain in Patients with Chemotherapy Induced Peripheral Neuropathy
por: van den Heuvel, Sandra A. S., et al.
Publicado: (2017) -
Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
por: Molassiotis, Alex, et al.
Publicado: (2019) -
Reliability and Validity of the Turkish Version of Chemotherapy-induced Peripheral Neuropathy Assessment Tool for Breast Cancer Patients Receiving Taxane Chemotherapy
por: Simsek, Neriman Yükseltürk, et al.
Publicado: (2018) -
Qualitative Evaluation of the Influence of Acute Oxaliplatin‐Induced Peripheral Neuropathy on Quality of Life and Activities of Daily Life
por: van Haren, Frank G.A.M., et al.
Publicado: (2021) -
The impact of SBF2 on taxane-induced peripheral neuropathy
por: Cunningham, Geneva M., et al.
Publicado: (2022)